Two leaders in science combine complementary best-in-class technologies for biologics manufacturing customers
Acute therapies continue to report strong growth compared to chronic ones.
The Phase 3 study is designed to bridge data collected from the vaccine efficacy trial conducted in India to the U.S. population
Kymriah, the first-ever FDA-approved CAR-T cell therapy, is currently available in 30 countries in one or more indications
It plans to double its network to 50 centres across India in the next three years
Torrent Pharmaceuticals Limited has reported consolidated financial results for the period ended September 30, 2021
The Board of Directors of Sanofi India Limited, at its meeting held on October 26th 2021 have approved the unaudited Standalone financial results of the company for the period ended September 30, 2021
ANG Lifesciences India Limited has reported financial results for the period ended September 30, 2021
A total of 12 generic medicines have been included in the list
Subscribe To Our Newsletter & Stay Updated
